Search results
4 simple lifestyle changes that can prevent type 2 diabetes
Yahoo Life UK· 8 hours agoHealth: Read more Diabetes signs and symptoms as weight loss drug gets authorised (Yahoo Life UK,...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA...
Benzinga via AOL· 7 hours agoFDA has cleared its Investigational New Drug Application for NPM-119, paving the way for the...
Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant
Exec Edge via Yahoo Finance· 5 hours agoBy Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of a phase 1...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
Vivani Medical Shares Up, FDA Cleared New Drug Application to Start Diabetes Trial
Morningstar· 6 hours agoBy Sabela Ojea Shares of Vivani Medical on Thursday climbed after the company said that the Food and Drug Administration cleared its investigational new drug</ ...
Mama June Shannon Reveals She Lost 30 Pounds Using Weight Loss Medication - E! Online
E! Online· 4 hours agoMama June Shannon is sharing insight into her weight loss journey. The Mama June: Family Crisis star...
Ozempic, Wegovy May Protect Kidney Health, New Research Finds
Health via Yahoo News· 3 days agoOzempic and Wegovy may be able to significantly reduce the risk of kidney complications, heart...
Diabetes time bomb as record 3.6 million are living with high blood sugar
Daily Express· 16 hours agoA record 3.6 million people are at high risk of developing diabetes as the nation battles an obesity...
Timing key for type 2 diabetes drug performance | Newswise
Newswise· 7 days agoDr Cong Xie postdoctoral research fellow in the Centre of Research Excellence in Translating...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 24 hours agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2